Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04457544

Spontaneous Coronary Artery Dissection National Swiss Registry

Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Dr. Sophie Degrauwe · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

Conditions

Timeline

Start date
2020-08-12
Primary completion
2025-06-30
Completion
2030-06-30
First posted
2020-07-07
Last updated
2022-11-16

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04457544. Inclusion in this directory is not an endorsement.